Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 996-1002

  Tormanen U ^a   Nuorva, K ^b   Soini, Y ^a,c   Paakko P ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b Ctrl Finland Health Care District ^*  (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Apoptosis; bcl 2 family; Bronchial dysplasia; Cell proliferation; p53

Indexed keywords

ANTIBODY; CYCLINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG DYSPLASIA; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRONCHI; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DNA FRAGMENTATION; EPITHELIAL CELLS; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; METAPLASIA; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REFERENCE VALUES; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033002693     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690159     Document Type: Article

References (44)

1. Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G and Thompson TC (1995) The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer 75: 522-529
2. Arai T and Kino I (1995) Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol 176: 37-44
3. Auerbach O, Gere B, Forman J, Petrick T, Smolin H, Muehsam G, Kassouny D and Stout A (1957) Changes in the bronchial epithelium in relation to smoking and cancer of the lung. N Engl J Med 256: 97-104
4. Auerbach O, Stout A, Hammond E and Garfinkel L (1962) Changes in bronchial epithelium in relation to sex, age, residence, smoking and pneumonia. N Engl J Med 267: 111-125
5. Auerbach O, Hammond E and Garfinkel L (1979) Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med 300: 381-386
6. H on chromosome 14 and near a transcriptional unit on chromosome 18. Cell 41: 899-906
7. Bardeesy N, Beckwith JB and Pelletier J (1995) Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 55: 215-219
8. Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M and Löhrs U (1996) Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer 77: 255-264
9. Bennett WP, Colby TV, Travis WD, Borkowski A, Jones RT, Lane DP, Metcalf RA, Samet JM, Takeshima Y, Gu JR, Vähäkangas KV, Soini Y, Pääkkö P, Welsh JA, Trump BF and Harris CC (1993) p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 53: 4817-4822
10. Birchall MA, Winterford CM, Allan DJ and Harmon BV (1995) Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study. Eur J Cancer Oral Oncol 31B: 380-383
11. Bodrug SE, Aimé-Sempé C, Sato T, Krajewski S, Hanada M and Reed JC (1995) Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Differ 2: 173-182
12. Eerola A-K, Törmänen U, Rainio P, Vähäkangas K, Sormunen R, Bloigu R, Lehto V-P and Pääkkö P (1997) Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity. J Pathol 181: 172-177
13. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
14. Hellquist HB, Olejnicka B, Jadner M, Andersson T and Sederholm C (1997) Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report. Br J Cancer 76: 175-179
15. Hirano T, Franzén B, Kato H, Ebihara Y and Auer G (1994) Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy and p53 expression. Am J Pathol 144: 296-302
16. Hockenbery DM, Zutter M, Hickey W, Nahm M and Korsmeyer SJ (1991) Bcl-2 protein is topographically restricted in tissues characterised by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-6965
17. Ishida M, Gomyo Y, Tatebe S, Ohfuji S and Ito H (1996) Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling. Virchows Arch 428: 229-235
18. Kerr JFR, Wyllie AH and Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257
19. King ED, Matteson J, Jacobs SC and Kyprianou N (1996) Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J Urol 155: 316-320
20. Lipponen PK and Aaltomaa S (1994) Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 173: 333-339
21. Lipponen P, Aaltomaa S, Kosma V-M and Syrjänen K (1994) Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 14: 2068-2073
22. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810
23. Koshida Y, Saegusa M and Okayasu I (1997) Apoptosis, cell proliferation and expression of bcl-2 and bax in gastric carcinomas: immunohistochemical and clinicopathological study. Br J Cancer 75: 367-373
24. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 6: 614-620
25. Lu, Q-L, Poulsom R, Wong L and Hanby AM (1993) bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169: 431-437
26. 1. forms an ion channel in synthetic lipid membranes. Nature 385: 353-357
27. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Schevehenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is required to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827
28. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
29. Nuorva K, Soini Y, Kamel D, Autio-Harmainen H, Risteli L, Risteli J, Vähäkangas K and Pääkkö P (1993) Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol 142: 725-732
30. Oltvai Z, Milliman C and Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619
31. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6
32. Saegusa M, Kamata Y, Isono M and Okayasu I (1996) bcl-2 expression is correlated with a low apoptotic index and is associated with progesterone receptor immunoreactivity in endometrial carcinomas. J Pathol 180: 275-282
33. Soini Y, Kamel D, Nuorva K, Lane DP, Vähäkangas K and Pääkkö P (1992) Low p53 protein expression in salivary gland tumours compared with lung carcinomas. Virchows Arch (Pathol Anat) 421: 415-420
34. Soini Y, Virkajärvi N, Lehto V-P and Pääkkö P (1996) Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer 73: 1025-1030
35. Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, Della Porta G and Pierotti MA (1992) Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52: 6079-6082
36. Staunton MJ and Gaffney EF (1995) Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol 103: 300-307
37. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM and Rabbits P (1992) p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989-1997
38. Törmänen U, Ferola A-K, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto V-P and Pääkkö P (1995) Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 55: 5595-5602
39. Tsujimoto Y, Finger LR, Yunis J, Nowell PC and Croce CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science 226: 1097-1099
40. Vähäkangas KH, Samet JM, Metcalf RA, Welsh JA, Bennett WP, Lane DP and Harris CC (1992) Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339: 576-580
41. Walker C, Robertson LJ, Myskow MW, Pendleton N and Dixon GR (1994) p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 70: 297-303
42. Walker C, Robertson L, Myskow M and Dixon G (1995) Expression of the bcl-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 72: 164-169
43. World Health Organization (1981) Histological Typing of Lung Tumours. International Classification of Tumours. No 1. World Health Organization: Geneva
44. Yang J, Xuesong L, Bhalla K, Caryn Naekyung K, Ibrado AM, Cai J, Tsung-IP, Jones DP and Wang X (1997) Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132